GP
IBB icon

GLG Partners’s iShares Biotechnology ETF IBB Stock Holding History

GLG Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,913
Closed -$277K – 477
2016
Q2 		$250K Buy
+2,913
New +$261K 0.01% 377
2015
Q4 		– Sell
-10,218
Closed -$1.03M – 487
2015
Q3 		$1.03M Buy
+10,218
New +$1.23M 0.03% 352
2015
Q2 		– Sell
-42,318
Closed -$4.84M – 483
2015
Q1 		$4.84M Sell
42,318
-19,611
-32% -$2.16M 0.16% 173
2014
Q4 		$6.26M Sell
61,929
-17,067
-22% -$1.66M 0.18% 136
2014
Q3 		$7.21M Buy
+78,996
New +$6.93M 0.17% 174

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

GLG Partners's IBB Position: Q3 2016 in Review

GLG Partners sold out of iShares Biotechnology ETF (IBB) in Q3 2016, closing a stake of 2,913 shares — an estimated $277K sold.

GLG Partners first reported a position in IBB in Q3 2014 and held it in 5 quarters. The position peaked at $7.21M in Q3 2014. 464 funds tracked by Wall St. Rank hold IBB as of Q3 2016.

  • GLG Partners reported no remaining iShares Biotechnology ETF position as of Q3 2016 after selling out during the quarter.
  • GLG Partners sold 2,913 iShares Biotechnology ETF shares in Q3 2016, an estimated $277K.
  • GLG Partners first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 5 quarters.
  • GLG Partners's iShares Biotechnology ETF position peaked at $7.21M in Q3 2014.
  • 464 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2016.

Based on GLG Partners's 13F filing for Q3 2016, filed 14 Nov 2016.